Talk:Atomoxetine: Difference between revisions
>DonVergas Actual formal draft for an Atomoxetine article. Based on verified pharmacological sources and merged with draft content from Talk. Formatted to match structure/style of Methylphenidate page. |
>DonVergas m Fixing inner links |
||
Line 1: | Line 1: | ||
== Atomoxetine == | == Atomoxetine == | ||
'''Atomoxetine''' (also known by the brand name '''Strattera''') is a prescription substance of the phenylpropylamine class. It acts as a [[sNRI|selective norepinephrine reuptake inhibitor (sNRI)]], and is used in the treatment of attention-deficit hyperactivity disorder (ADHD). | '''Atomoxetine''' (also known by the brand name '''Strattera''') is a prescription substance of the [[chemical class::phenylpropylamine]] class. It acts as a [[sNRI|selective norepinephrine reuptake inhibitor (sNRI)]], and is used in the treatment of attention-deficit hyperactivity disorder (ADHD). | ||
Unlike stimulant medications such as [[methylphenidate]] or [[amphetamine]], atomoxetine is classified as a non-stimulant therapeutic agent with a low abuse potential. It exerts its effects by increasing extracellular levels of [[norepinephrine]], particularly within the prefrontal cortex. Recent research suggests that atomoxetine also mildy inhibits the reuptake of [[serotonin]] at clinical dosages as well. | Unlike [[psychoactive class::stimulant]] medications such as [[methylphenidate]] or [[amphetamine]], atomoxetine is classified as a [[Nootropics|non-stimulant therapeutic agent]] with a low abuse potential. It exerts its effects by increasing extracellular levels of [[norepinephrine]], particularly within the prefrontal cortex. Recent research suggests that atomoxetine also mildy inhibits the reuptake of [[serotonin]] at clinical dosages as well. | ||
== Chemistry == | == Chemistry == | ||
Line 72: | Line 72: | ||
* [[Methylphenidate]] | * [[Methylphenidate]] | ||
* [[Amphetamine]] | * [[Amphetamine]] | ||
* [[Norepinephrine]] | * [[Norepinephrine]] | ||